Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Lymphoma, Non-Hodgkin 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Lymphoma, Follicular 2Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphohistiocytosis, Hemophagocytic 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 46fludarabine phosphate 34Peripheral Blood Stem Cell Transplantation 29Whole-Body Irradiation 22Etoposide 22Tacrolimus 20Methotrexate 20Mycophenolic Acid 19Cytarabine 19Dexamethasone 17Vincristine 16Filgrastim 16Busulfan 16venetoclax 15Antilymphocyte Serum 15Rituximab 13Prednisone 13Cyclosporine 12Doxorubicin 11Melphalan 9Calcium Dobesilate 9nelarabine 8Bortezomib 8merphos 7Radiotherapy 7Methylprednisolone 7Granulocyte Colony-Stimulating Factor 7Azacitidine 7prednylidene 6pegaspargase 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × EPOCH protocol × Clear all
NCT05996185 2026-04-14

Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma

Yale University

Phase 2 Recruiting
22 enrolled
DermatologicLymphoidOther hematologic neoplasm

Recurrence, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡